Sun Pharma takes steps to limit damage, discontinues AML and unwinds loans
newsdepo.com
In a filing to stock exchanges on January 22, the company said its distribution related to its domestic formulations business shall be transitioned from AML, the current distributor, to a wholly owned subsidiary of Sun PharmaSun Pharma takes steps to limit damage, discontinues AML and unwinds loans
In a filing to stock exchanges on January 22, the company said its distribution related to its domestic formulations business shall be transitioned from AML, the current distributor, to a wholly owned subsidiary of Sun Pharma Read more